Ons laatste nieuws
Why Indian Tech Companies Are Choosing the Netherlands as Their European Base
Amsterdam, Thursday, 4 June 2026.
A formal Strategic Partnership signed in May 2026 is turning the Netherlands into the preferred European entry point for Indian technology firms — backed by a €10 million joint research fund and a Tata-ASML chip manufacturing deal.
Laatste nieuws in green
Dutch Agritech Startup Secures €2 Million to Bring Hyperlocal Weather Data to European Farmers
Maastricht, Wednesday, 3 June 2026.
AgroExact, already trusted by thousands of Dutch farmers for ultra-local weather insights, is taking its precision data network Europe-wide — with climate pressure on food systems making this expansion more urgent than ever.
Laatste nieuws in community
The Netherlands Is Sitting on a Gold Mine of Scientific Knowledge — But Failing to Share It
Amsterdam, Wednesday, 3 June 2026.
Dutch universities produce world-class research, yet a structural gap prevents that knowledge from reaching entrepreneurs and society. Graduate Ventures has backed over 80 startups with €130 million, but fragmentation across regions remains the critical obstacle to building Europe’s next innovation powerhouse.
Laatste nieuws in data
EU Adopts Unified Cyber Incident Reporting Templates, Cutting Red Tape for Thousands of Companies
Brussels, Tuesday, 2 June 2026.
Companies operating across EU borders now face a single reporting standard for cyber incidents, replacing a fragmented patchwork of national requirements — with full mandatory implementation expected by October 2026.
Laatste nieuws in semicon
Europe Bets on Homegrown Tech to Break Free from US and Chinese Digital Dominance
Brussels, Wednesday, 3 June 2026.
The European Commission launched its Tech Sovereignty Package on June 3, 2026, targeting semiconductors, AI, cloud, and open source — a direct response to US and Chinese firms controlling roughly 70% of Europe’s cloud market.
Laatste nieuws in bio
A New Diabetes Pill Builds on Muscle Power — Without the Side Effects of Ozempic
Boston, Thursday, 4 June 2026.
Researchers from Karolinska Institutet have developed an oral pill that burns fat by activating skeletal muscle metabolism — preserving muscle mass where Ozempic cannot, in a market projected to exceed $100 billion by 2030.